Abstract
Probiotics, or living microbes used as therapeutic agents, have been used for the treatment and prevention of diverse types of diseases. However, the focus of the application of these probiotics has been mainly on individuals and not on widespread outbreak prevention. As continued efforts in infection control and antibiotic treatments fail to stem the increasing rates of nosocomial outbreaks, probiotics may offer an alternative strategy for controlling these infections. The advantages of probiotics are that they are natural, have a long history of use, are well-studied, have a low risk of antibiotic-resistance and have an excellent safety profile.A review of the literature for randomised controlled trials using probiotics found 22 studies that were applicable to this aim. The most promising targets for probiotics are Clostridium difficile outbreaks, antibiotic-associated diarrhoea (AAD) and rotaviral outbreaks in paediatric patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
